vs

Side-by-side financial comparison of KENNAMETAL INC (KMT) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.

KENNAMETAL INC is the larger business by last-quarter revenue ($529.5M vs $493.8M, roughly 1.1× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 6.4%, a 0.4% gap on every dollar of revenue. On growth, KENNAMETAL INC posted the faster year-over-year revenue change (9.8% vs -1.7%). Over the past eight quarters, KENNAMETAL INC's revenue compounded faster (1.3% CAGR vs -0.1%).

Kennametal, Inc. is a manufacturer of high-performance cutting tools and engineered components used in the aerospace, defense, transportation and oil and gas drilling industries. Its customer base is global.

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

KMT vs MD — Head-to-Head

Bigger by revenue
KMT
KMT
1.1× larger
KMT
$529.5M
$493.8M
MD
Growing faster (revenue YoY)
KMT
KMT
+11.6% gap
KMT
9.8%
-1.7%
MD
Higher net margin
MD
MD
0.4% more per $
MD
6.8%
6.4%
KMT
Faster 2-yr revenue CAGR
KMT
KMT
Annualised
KMT
1.3%
-0.1%
MD

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
KMT
KMT
MD
MD
Revenue
$529.5M
$493.8M
Net Profit
$33.9M
$33.7M
Gross Margin
32.8%
Operating Margin
9.9%
9.9%
Net Margin
6.4%
6.8%
Revenue YoY
9.8%
-1.7%
Net Profit YoY
89.0%
10.5%
EPS (diluted)
$0.44
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KMT
KMT
MD
MD
Q4 25
$529.5M
$493.8M
Q3 25
$498.0M
$492.9M
Q2 25
$516.4M
$468.8M
Q1 25
$486.4M
$458.4M
Q4 24
$482.1M
$502.4M
Q3 24
$481.9M
$511.2M
Q2 24
$543.3M
$504.3M
Q1 24
$515.8M
$495.1M
Net Profit
KMT
KMT
MD
MD
Q4 25
$33.9M
$33.7M
Q3 25
$23.3M
$71.7M
Q2 25
$21.6M
$39.3M
Q1 25
$31.5M
$20.7M
Q4 24
$17.9M
$30.5M
Q3 24
$22.1M
$19.4M
Q2 24
$37.2M
$-153.0M
Q1 24
$19.0M
$4.0M
Gross Margin
KMT
KMT
MD
MD
Q4 25
32.8%
Q3 25
31.0%
Q2 25
28.2%
Q1 25
32.1%
Q4 24
30.1%
Q3 24
31.3%
Q2 24
31.5%
Q1 24
29.7%
Operating Margin
KMT
KMT
MD
MD
Q4 25
9.9%
9.9%
Q3 25
7.5%
13.8%
Q2 25
6.1%
12.8%
Q1 25
9.1%
7.0%
Q4 24
6.6%
7.8%
Q3 24
7.5%
6.6%
Q2 24
11.3%
-31.3%
Q1 24
6.8%
3.2%
Net Margin
KMT
KMT
MD
MD
Q4 25
6.4%
6.8%
Q3 25
4.7%
14.5%
Q2 25
4.2%
8.4%
Q1 25
6.5%
4.5%
Q4 24
3.7%
6.1%
Q3 24
4.6%
3.8%
Q2 24
6.8%
-30.3%
Q1 24
3.7%
0.8%
EPS (diluted)
KMT
KMT
MD
MD
Q4 25
$0.44
$0.40
Q3 25
$0.30
$0.84
Q2 25
$0.28
$0.46
Q1 25
$0.41
$0.24
Q4 24
$0.23
$0.37
Q3 24
$0.28
$0.23
Q2 24
$0.47
$-1.84
Q1 24
$0.24
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KMT
KMT
MD
MD
Cash + ST InvestmentsLiquidity on hand
$129.3M
$375.2M
Total DebtLower is stronger
$597.2M
$570.5M
Stockholders' EquityBook value
$1.3B
$865.9M
Total Assets
$2.6B
$2.2B
Debt / EquityLower = less leverage
0.45×
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KMT
KMT
MD
MD
Q4 25
$129.3M
$375.2M
Q3 25
$103.5M
$340.1M
Q2 25
$140.5M
$224.7M
Q1 25
$97.5M
$99.0M
Q4 24
$121.2M
$229.9M
Q3 24
$119.6M
$103.8M
Q2 24
$128.0M
$19.4M
Q1 24
$92.1M
$8.0M
Total Debt
KMT
KMT
MD
MD
Q4 25
$597.2M
$570.5M
Q3 25
$597.0M
$577.2M
Q2 25
$596.8M
$583.9M
Q1 25
$596.6M
$590.5M
Q4 24
$596.4M
$597.1M
Q3 24
$596.2M
Q2 24
$596.0M
Q1 24
$595.8M
Stockholders' Equity
KMT
KMT
MD
MD
Q4 25
$1.3B
$865.9M
Q3 25
$1.3B
$890.7M
Q2 25
$1.3B
$833.8M
Q1 25
$1.2B
$789.2M
Q4 24
$1.2B
$764.9M
Q3 24
$1.3B
$732.5M
Q2 24
$1.2B
$706.5M
Q1 24
$1.3B
$856.2M
Total Assets
KMT
KMT
MD
MD
Q4 25
$2.6B
$2.2B
Q3 25
$2.5B
$2.2B
Q2 25
$2.5B
$2.1B
Q1 25
$2.5B
$2.0B
Q4 24
$2.4B
$2.2B
Q3 24
$2.5B
$2.1B
Q2 24
$2.5B
$2.0B
Q1 24
$2.5B
$2.2B
Debt / Equity
KMT
KMT
MD
MD
Q4 25
0.45×
0.66×
Q3 25
0.46×
0.65×
Q2 25
0.46×
0.70×
Q1 25
0.48×
0.75×
Q4 24
0.49×
0.78×
Q3 24
0.47×
Q2 24
0.48×
Q1 24
0.47×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KMT
KMT
MD
MD
Operating Cash FlowLast quarter
$55.1M
$114.1M
Free Cash FlowOCF − Capex
$42.4M
FCF MarginFCF / Revenue
8.0%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
1.63×
3.39×
TTM Free Cash FlowTrailing 4 quarters
$99.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KMT
KMT
MD
MD
Q4 25
$55.1M
$114.1M
Q3 25
$17.5M
$137.3M
Q2 25
$78.6M
$137.2M
Q1 25
$28.8M
$-117.5M
Q4 24
$55.2M
$133.0M
Q3 24
$45.7M
$91.8M
Q2 24
$113.6M
$107.0M
Q1 24
$75.2M
$-125.2M
Free Cash Flow
KMT
KMT
MD
MD
Q4 25
$42.4M
Q3 25
$-5.5M
Q2 25
$57.1M
Q1 25
$5.3M
Q4 24
$35.9M
Q3 24
$21.0M
Q2 24
$90.3M
Q1 24
$48.4M
FCF Margin
KMT
KMT
MD
MD
Q4 25
8.0%
Q3 25
-1.1%
Q2 25
11.1%
Q1 25
1.1%
Q4 24
7.5%
Q3 24
4.4%
Q2 24
16.6%
Q1 24
9.4%
Capex Intensity
KMT
KMT
MD
MD
Q4 25
2.4%
Q3 25
4.6%
Q2 25
4.2%
Q1 25
4.8%
Q4 24
4.0%
Q3 24
5.1%
Q2 24
4.3%
Q1 24
5.2%
Cash Conversion
KMT
KMT
MD
MD
Q4 25
1.63×
3.39×
Q3 25
0.75×
1.91×
Q2 25
3.64×
3.49×
Q1 25
0.92×
-5.66×
Q4 24
3.08×
4.36×
Q3 24
2.07×
4.72×
Q2 24
3.06×
Q1 24
3.96×
-31.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KMT
KMT

Metal Cutting$331.1M63%
Infrastructure$198.5M37%

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

Related Comparisons